Multicenter Real-World Observational Study of Pargeverine/Lysine Clonixinate in Acute Visceral Colicky Pain
In real-world clinical practice, the fixed-dose combination of pargeverine and lysine clonixinate was associated with early and sustained, clinically meaningful pain reduction across multiple forms of acute visceral colicky pain, with a favorable safety and tolerability profile, supporting its relevance as a short-term therapeutic option in mild to severe acute pain.
Authors
- Brandon Bautista-Becerril (ORCID: https://orcid.org/0000-0001-5975-6724)
- Samuel Sevilla-Fuentes (ORCID: https://orcid.org/0000-0003-0496-2920)
- Ramcés Falfán-Valencia
- Luis Ángel Mendoza-Vargas
- José Francisco Araiza-Rodríguez
- Gerardo E. Espinosa-Estrada
- Pedro Moreno-Chavez
Institutions
- Hospital General de México (MX)
- Instituto Nacional de Enfermedades Respiratorias (MX)
- Hospital General De Zona (MX)
- Centro Universitario Didaskalos (MX)
- Universidad Autónoma de Zacatecas "Francisco García Salinas" (MX)
Publication Details
- Journal
- Medicina
- Published
- 2026-04-07
- DOI
- https://doi.org/10.3390/medicina62040706
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00